Table I.

Effect of TSIIA on body weight and blood glucose concentration.

	Body weight (g)			Blood glucose concentration (mmol/l)
Group	Prior to STZ injection	2 days post-STZ injection	6 weeks post-STZ injection	Prior to STZ injection	2 days post-STZ injection	6 weeks post-STZ injection
Control	133.27±3.67	141.59±4.92	404.85±31.48	5.71±0.55	6.25±0.64	5.67±0.43
Diabetes	134.16±4.03	142.02±5.63	299.26±47.14a	5.64±0.66	21.87±3.35a	25.07±2.59a
L-TSIIA	136.40±4.23	144.20±5.51	311.99±49.92a	6.12±0.79	21.78±4.73a	20.78±2.88a,b
H-TSIIA	130.08±5.39	138.68±6.55	289.50±42.18a	5.68±0.52	23.89±4.18a	23.46±3.05a

Data are presented as the mean ± standard deviation (n=10).

^aP<0.01 vs. control group

^bP<0.05 vs. diabetes group. TSIIA, Tanshinone IIA; STZ, streptozotocin; Diabetes, STZ-induced diabetic rats; L-TSIIA, diabetic rat treated with low dose TSIIA (2 mg/kg/day); H-TSIIA, diabetic rat treated with high dose TSIIA (4 mg/kg/day).